PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
30.36%
Revenue growth of 30.36% while FSLR is flat. Bruce Berkowitz would check if a small edge can widen further.
101.11%
Gross profit growth of 101.11% while FSLR is zero. Bruce Berkowitz would see if minimal improvements could expand further.
665.55%
EBIT growth of 665.55% while FSLR is zero. Bruce Berkowitz would see if small gains can be scaled further.
665.55%
Operating income growth of 665.55% while FSLR is zero. Bruce Berkowitz would see if this modest edge can become significant.
2011.37%
Net income growth of 2011.37% while FSLR is zero. Bruce Berkowitz would see if small gains can accelerate into a larger gap.
1804.76%
EPS growth of 1804.76% while FSLR is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
2005.26%
Diluted EPS growth of 2005.26% while FSLR is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
4.77%
Share change of 4.77% while FSLR is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
3.70%
Diluted share change of 3.70% while FSLR is zero. Bruce Berkowitz might see a minor difference that could widen over time.
No Data
No Data available this quarter, please select a different quarter.
169.34%
OCF growth of 169.34% while FSLR is zero. Bruce Berkowitz would see if small gains can expand into a larger competitive lead.
68.26%
FCF growth of 68.26% while FSLR is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-8.27%
Negative 10Y revenue/share CAGR while FSLR stands at 551.85%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-8.27%
Negative 5Y CAGR while FSLR stands at 551.85%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-8.27%
Negative 3Y CAGR while FSLR stands at 551.85%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-93.35%
Negative 10Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-93.35%
Negative 5Y OCF/share CAGR while FSLR is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
-93.35%
Negative 3Y OCF/share CAGR while FSLR stands at 0.00%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
123.37%
Net income/share CAGR above 1.5x FSLR's 74.03% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
123.37%
5Y net income/share CAGR above 1.5x FSLR's 74.03%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
123.37%
3Y net income/share CAGR above 1.5x FSLR's 74.03%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
38.43%
AR growth of 38.43% while FSLR is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
24.59%
Inventory growth of 24.59% while FSLR is zero. Bruce Berkowitz wonders if we anticipate a new wave of demand or risk being stuck with extra product.
63.80%
Asset growth of 63.80% while FSLR is zero. Bruce Berkowitz checks if modest expansions can create a longer-term lead.
70.33%
BV/share growth of 70.33% while FSLR is zero. Bruce Berkowitz sees if small growth can compound into a strong advantage.
No Data
No Data available this quarter, please select a different quarter.
29.66%
R&D growth of 29.66% while FSLR is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
13.79%
SG&A growth of 13.79% while FSLR is zero. Bruce Berkowitz sees more spend on admin or marketing, expecting stronger top-line in return.